Home » Treatments/Research » Fellowship Program » Meet our Fellows

Meet our Fellows

Vasculitis Fellows

In just a few short years, VCRC-VF Fellowships have provided advanced training to over 25 physician-researchers. Each year new fellows are added to this total; increasing the number of highly qualified physicians and researchers who can diagnose, treat, and improve the lives of people living with vasculitis.

Logo for V-BOLD Vasculitis Foundation. The word “V-BOLD” is in large navy text with a magenta compass design inside the letter O. Below, “Vasculitis Foundation” appears in magenta capital letters within a horizontal box. The tagline underneath reads: “Science. Innovation. Achievement.” in navy text.

2024-2025 VCRC-VF Fellows

2024–2025
Sam Falde, MD
Mayo Clinic

Rochester, Minnesota

Fellowship Focus:
Improving treatment outcomes by refining classification criteria for ANCA-associated vasculitis. 

2024–2025
Ruoning Ni, MD
Cleveland Clinic

Cleveland, Ohio

Fellowship Focus:
Gaining skills, experience, and expertise to guide her in opening a vasculitis center in Iowa. 

2022-2024 VCRC-VF Fellows

2023–2024
Mats Junek, MD, MSc
McMaster University

Hamilton, Ontario, Canada

Research Interests:
Building clinical models that predict relapse risk. This will help patients and doctors create treatment plans that balance relapse risk with medication side effects.

2023–2024
Roger Yang, MD
Penn Vasculitis Center

Philadelphia, Pennsylvania

Research Interests:
Developing effective sinonasal treatments for Granulomatosis with Polyangiitis (GPA) and immunomodulatory therapies for Relapsing Polychondritis.

2022–2023
Mohanad M. Elfishawi, MBBCh, MS
Mayo Clinic

Rochester, Minnesota

Research Interests:
Investigating metabolic risk factors for Giant Cell Arteritis (GCA) and predicting patients’ risk of developing an aortic aneurysm or dissection (when a tear occurs in the inner layer of the aorta).

2022–2023
Marta Casal Moura, MD, MSc, MSPH
Mayo Clinic

Rochester, Minnesota

Research Interests:
Identifying which Anca-Associated Vasculitis (AAV) glomerulonephritis—kidney inflammation—patients respond to plasma exchange and finding relapse predictors in Giant Cell Arteritis (GCA).

2022–2023
Gözde Kübra Yardimci, MD
Mount Sinai Hospital, University of Ontario

Cleveland, Ohio

Research Interests:
Preventing severe ischemic events (lack of blood flow to organs and/or tissue) in Takayasu arteritis and Behçet’s syndrome.

Jessica Bloom, MD
University of Colorado-Denver
2021–2022

Kinanah Yaseen, MD
Cleveland Clinic
2020–2021

Stephanie Garner, MD
McMaster University
2019–2020

Sebastian E. Sattui, MD
Hospital for Special Surgery
2019–2020

Alvise Berti, MD
Santa Chiara Hospital
2019–2020

Kevin Byram, MD
Cleveland Clinic Center for Vasculitis Care and Research
2017–2018

Kaitlin Quinn, MD
MedStar Georgetown University Hospital
2017–2018

Jennifer Rodrigues, MD
McMaster University
2016–2017

Amy Archer, MD, PhD
University of Pennsylvania
2016–2017

Medha Soowamber, MD
University of Toronto
2015–2016

Natasha Dehghan, MD
University of Pennsylvania
2014–2015

Rennie Rhee, MD, MSCE
University of Pennsylvania
2014–2016

Elizabeth Brant, MD
University of North Carolina, Chapel Hill
2012–2014

Christian Pagnoux, MD, MPA
University of Toronto
2010–2012

Tanaz Kermani, MD, MS
Mayo Clinic 2010–2011

Atul Khasnis, MD, MS
Cleveland Clinic
2009–2010

Eamonn Molloy, MD, MS, MRCPI
Cleveland Clinic
2007–2008

Peter Grayson, MD, MS
Boston University
2006–2008

Francisco Silva, MD, MS
Mayo Clinic
2006–2008

Gunnar Tomasson, MD, PhD
Boston University
2006–2008

Alicia Rodríguez-Pla, MD, PhD
Johns Hopkins
2005–2007

Alfred D. Mahr, MD, MPH, PhD
Boston University
2005–2007

Curry Koening, MD, MS
Cleveland Clinic
2005–2007